Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis

Autophagy

Volumn 11, Issue 7, 2015, Pages 1130-1145

  Lenoir, Olivia ^a,b   Jasiek, Magali ^a,b   Hénique, Carole ^a,b   Guyonnet, Léa ^a,b   Hartleben, Björn ^c   Bork, Tillmann ^c   Chipont, Anna ^a,b   Flosseau, Kathleen ^a,b   Bensaada, Imane ^a,b   Schmitt, Alain ^b,d,e   Massé, Jean Marc ^b,d,e   Souyri, Michéle ^d   Huber, Tobias B ^c,f   Tharaux, Pierre Louis ^a,b,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d CNRS   (France)

^e INSTITUT COCHIN   (France)

^f UNIVERSITY OF FREIBURG   (Germany)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Autophagy; Diabetic nephropathy; Endothelial cells; Podocytes; Proteinuria; Sclerosis

Indexed keywords

ALBUMIN; AUTOPHAGY PROTEIN 5; GLUCOSE; ATG5 PROTEIN, MOUSE; AUTOPHAGY RELATED PROTEIN 5; CRE RECOMBINASE; INTEGRASE; MICROTUBULE ASSOCIATED PROTEIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL CULTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM; ENDOTHELIUM CELL; GLOMERULAR FILTRATION BARRIER; GLOMERULUS BASEMENT MEMBRANE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; MACROMOLECULE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERICYTE; PODOCYTE; PROTEIN DEPLETION; ULTRAFILTRATION; ANIMAL; APOPTOSIS; C57BL MOUSE; DEFICIENCY; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENE DELETION; GLOMERULUS FILTRATION RATE; MESANGIUM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; GENE DELETION; GLOMERULAR FILTRATION RATE; GLUCOSE; INTEGRASES; MESANGIAL CELLS; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; PHENOTYPE; PODOCYTES;

EID: 84942250072     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2015.1049799     Document Type: Article

References (96)

1. Van Buren PN, Toto R. Current update in the management of diabetic nephropathy. Curr Diabetes Rev 2013; 9: 62-77; PMID: 23167665; http://dx. doi. org/10. 2174/157339913804143207.
2. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 2000; 97: 8015-20; PMID: 10859350; http://dx. doi. org/10. 1073/pnas. 120055097.
3. Ziyadeh FN, Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 2004; 15 Suppl 1: S55-7; PMID: 14684674; http://dx. doi. org/10. 1097/01. ASN. 0000093460. 24823. 5B.
4. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol 2011; 170: 36-47; PMID: 21659756; http://dx. doi. org/10. 1159/000324942.
5. Kawagishi T, Matsuyoshi M, Emoto M, Taniwaki H, Kanda H, Okuno Y, Inaba M, Ishimura E, Nishizawa Y, Morii H. Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 1999; 19: 2509-16; PMID: 10521381; http://dx. doi. org/10. 1161/01. ATV. 19. 10. 2509.
6. Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S, Maekawa K, Hosoi M, Inaba M, Emoto M, et al. Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int 1997; 51: 1920-7; PMID: 9186883; http://dx. doi. org/10. 1038/ki. 1997. 261.
7. Eleftheriadis T, Antoniadi G, Pissas G, Liakopoulos V, Stefanidis I. The renal endothelium in diabetic nephropathy. Ren Fail 2013; 35: 592-9; PMID: 23472883; http://dx. doi. org/10. 3109/088602 2X. 2013. 773836.
8. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-76; PMID: 17475821; http://dx. doi. org/10. 1681/ASN. 2006121304.
9. Stitt-Cavanagh E, MacLeod L, Kennedy C. The podocyte in diabetic kidney disease. ScientificWorldJournal 2009; 9: 1127-39; PMID: 19838599; http://dx. doi. org/10. 1100/tsw. 2009. 133.
10. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008; 4: 39-45; PMID: 18220694; http://dx. doi. org/10. 2174/157339908783502370.
11. Reddy GR, Kotlyarevska K, Ransom RF, Menon RK. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 2008; 17: 32-6; PMID: 18090667; http://dx. doi. org/10. 1097/MNH. 0b013e3282f2904d.
12. Huber TB, Edelstein CL, Hartleben B, Inoki K, JiangM, Koya D, Kume S, Lieberthal W, Pallet N, Quiroga A, et al. Emerging role of autophagy in kidney function, diseases and aging. Autophagy 2012; 8: 1009-31; PMID: 22692002; http://dx. doi. org/10. 4161/auto. 19821.
13. Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120: 1084-96; PMID: 20200449; http://dx. doi. org/10. 1172/JCI39492.
14. Boya P, Reggiori F, Codogno P. Emerging regulation and functions of autophagy. Nat Cell Biol 2013; 15: 713-20; PMID: 23817233; http://dx. doi. org/10. 1038/ncb2788.
15. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 1845-6; PMID: 23656658; http://dx. doi. org/10. 1056/NEJMra1205406.
16. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221: 3-12; PMID: 20225336; http://dx. doi. org/10. 1002/path. 2697.
17. ShibataM, Lu T, Furuya T, Degterev A, Mizushima N, Yoshimori T, MacDonald M, Yankner B, Yuan J. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 2006; 281: 14474-85; PMID: 16522639; http://dx. doi. org/10. 1074/jbc. M600364200.
18. Yang Z, KlionskyDJ. Eaten alive: a history ofmacroautophagy. Nat Cell Biol 2010; 12: 814-22; PMID: 20811353; http://dx. doi. org/10. 1038/ncb0910-814.
19. Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ, Czaja MJ. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 2009; 119: 3329-39; PMID: 19855132.
20. Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011; 146: 682-95; PMID: 21884931; http://dx. doi. org/10. 1016/j. cell. 2011. 07. 030.
21. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301: 1387-91; PMID: 12958363; http://dx. doi. org/10. 1126/science. 1087782.
22. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 2010; 107: 14164-9; PMID: 20660724; http://dx. doi. org/10. 1073/pnas. 1009485107.
23. Jia G, Cheng G, Agrawal DK. Autophagy of vascular smooth muscle cells in atherosclerotic lesions. Autophagy 2007; 3: 63-4; PMID: 17172800; http://dx. doi. org/10. 4161/auto. 3427.
24. Kume S, Thomas MC, Koya D. Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes 2012; 61: 23-9; PMID: 22187371; http://dx. doi. org/10. 2337/db11-0555.
25. Kume S, Uzu T, Maegawa H, Koya D. Autophagy: a novel therapeutic target for kidney diseases. Clin Exp Nephrol 2012; 16: 827-32; PMID: 22971965; http://dx. doi. org/10. 1007/s10157-012-0695-2.
26. Weide T, Huber TB. Implications of autophagy for glomerular aging and disease. Cell Tissue Res 2011; 343: 467-73; PMID: 21286756; http://dx. doi. org/10. 1007/s00441-010-1115-0.
27. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26; PMID: 2668076; http://dx. doi. org/10. 1007/BF00285287.
28. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 2013; 17: 20-33; PMID: 23312281; http://dx. doi. org/10. 1016/j. cmet. 2012. 11. 012.
29. Advani A, Gilbert RE. The endothelium in diabetic nephropathy. Semin Nephrol 2012; 32: 199-207; PMID: 22617769; http://dx. doi. org/10. 1016/j. semnephrol. 2012. 02. 006.
30. Goligorsky MS, Chen J, Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 2001; 37: 744-8; PMID: 11230367; http://dx. doi. org/10. 1161/01. HYP. 37. 2. 744.
31. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-50; PMID: 17202420; http://dx. doi. org/10. 1681/ASN. 2006050459.
32. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006; 55: 1127-32; PMID: 16567538; http://dx. doi. org/10. 2337/diabetes. 55. 04. 06. db05-1619.
33. Oltean S, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Kaura A, Arkill KP, Harris K, Symonds C, et al. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy. J Am Soc Nephrol 2014; PMID: 25542969; http://dx. doi. org/10. 1681/ASN. 2014040350.
34. Lenoir O, Milon M, Virsolvy A, Henique C, Schmitt A, Masse JM, Kotelevtsev Y, Yanagisawa M, Webb DJ, Richard S, et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J Am Soc Nephrol 2014; 25: 1050-62; PMID: 24722437; http://dx. doi. org/10. 1681/ASN. 2013020195.
35. Sarafidis PA, Lasaridis AN. Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy. Nat Rev Nephrol 2010; 6: 447-9; PMID: 20664627; http://dx. doi. org/10. 1038/nrneph. 2010. 86.
36. Ding SS, Qiu C, Hess P, Xi JF, Zheng N, Clozel M. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat. J Cardiovasc Pharmacol 2003; 42: 48-54; PMID: 12827026; http://dx. doi. org/10. 1097/00005344-200307000-00008.
37. Bruno CM, Meli S, Marcinno M, Ierna D, Sciacca C, Neri S. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents 2002; 16: 114-7; PMID: 12144123.
38. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993; 122: 149-56; PMID: 8340699.
39. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69: 1654-61; PMID: 16541023; http://dx. doi. org/10. 1038/sj. ki. 5000294.
40. Liu E, Morimoto M, Kitajima S, Koike T, Yu Y, Shiiki H, Nagata M, Watanabe T, Fan J. Increased Expression of Vascular Endothelial Growth Factor in Kidney Leads to Progressive Impairment of Glomerular Functions. J Am Soc Nephrol 2007; 18: 2094-104; PMID: 17554151; http://dx. doi. org/10. 1681/ASN. 2006010075.
41. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121: 2278-89; PMID: 21606590; http://dx. doi. org/10. 1172/JCI46322.
42. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20: 1981-91; PMID: 19211835; http://dx. doi. org/10. 1091/mbc. E08-12-1248.
43. Hoyer-Hansen M, Jaattela M. AMP-activated protein kinase: a universal regulator of autophagy? Autophagy 2007; 3: 381-3; PMID: 17457036; http://dx. doi. org/10. 4161/auto. 4240.
44. Mack HI, Zheng B, Asara JM, Thomas SM. AMPKdependent phosphorylation of ULK1 regulates ATG9 localization. Autophagy 2012; 8: 1197-214; PMID: 22932492; http://dx. doi. org/10. 4161/auto. 20586.
45. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A 2008; 105: 3374-9; PMID: 18296641; http://dx. doi. org/10. 1073/pnas. 0712145105.
46. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132-41; PMID: 21258367; http://dx. doi. org/10. 1038/ncb2152.
47. Park EY, Park JB. High glucose-induced oxidative stress promotes autophagy through mitochondrial damage in rat notochordal cells. Int Orthop 2013; 37: 2507-14; PMID: 23907350; http://dx. doi. org/10. 1007/s00264-013-2037-8.
48. Chen H, Luo Z, Sun W, Zhang C, Sun H, Zhao N, Ding J, Wu M, Li Z, Wang H. Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells. Cancer Lett 2013; 336: 204-12; PMID: 23652197; http://dx. doi. org/10. 1016/j. canlet. 2013. 04. 031.
49. Ma T, Zhu J, Chen X, Zha D, Singhal PC, Ding G. High glucose induces autophagy in podocytes. Exp Cell Res 2013; 319: 779-89; PMID: 23384600; http://dx. doi. org/10. 1016/j. yexcr. 2013. 01. 018.
50. Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP, Hartleben G, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011; 121: 2197-209; PMID: 21606591; http://dx. doi. org/10. 1172/JCI44774.
51. Wu L, Feng Z, Cui S, Hou K, Tang L, Zhou J, Cai G, Xie Y, Hong Q, Fu B, et al. Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. PLoS One 2013; 8: e63799; PMID: 23667674; http://dx. doi. org/10. 1371/journal. pone. 0063799.
52. Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol 2008; 445: 77-88; PMID: 18425443; http://dx. doi. org/10. 1007/978-1-59745-157-4_4.
53. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544; PMID: 22966490; http://dx. doi. org/10. 4161/auto. 19496.
54. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-26; PMID: 20144757; http://dx. doi. org/10. 1016/j. cell. 2010. 01. 028.
55. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441: 885-9; PMID: 16625204; http://dx. doi. org/10. 1038/nature04724.
56. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35: 39-42; PMID: 12481297; http://dx. doi. org/10. 1002/gene. 10164.
57. Oberlin E, El Hafny B, Petit-Cocault L, Souyri M. Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression. Int J Dev Biol 2010; 54: 1165-73; PMID: 20711993; http://dx. doi. org/10. 1387/ijdb. 103121eo.
58. Ritz E, Zeng XX, Rychlik I. Clinical manifestation and natural history of diabetic nephropathy. Contrib Nephrol 2011; 170: 19-27; PMID: 21659754; http://dx. doi. org/10. 1159/000324939.
59. Pirart J.; Diabetes mellitus and its degenerative complications: a prospective study of 4, 400 patients observed between 1947 and 1973 (author's transl). Diabete Metab 1977; 3: 97-107; PMID: 892130.
60. Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008; 31: 2198-202; PMID: 18650371; http://dx. doi. org/10. 2337/dc08-0864.
61. Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, Mussap M. Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol 2006; 17: S86-9; PMID: 16565255; http://dx. doi. org/10. 1681/ASN. 2005121343.
62. Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J. Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care 1996; 19: 313-7; PMID: 8729152; http://dx. doi. org/10. 2337/diacare. 19. 4. 313.
63. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; 2: 1300-4; PMID: 2878175; http://dx. doi. org/10. 1016/S0140-6736(86)91433-9.
64. Feldt-Rasmussen B. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control. Transplant Proc 1994; 26: 371-2; PMID: 8171466.
65. Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, Kominami E, Tomino Y. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J 2003; 17: 1165-7; PMID: 12709412.
66. Sato S, Adachi A, Sasaki Y, Dai W. Autophagy by podocytes in renal biopsy specimens. J Nihon Med Sch 2006; 73: 52-3; http://dx. doi. org/10. 1272/jnms. 73. 52.
67. Sato S, Kitamura H, Adachi A, Sasaki Y, Ghazizadeh M. Two types of autophagy in the podocytes in renal biopsy specimens: ultrastructural study. J Submicrosc Cytol Pathol 2006; 38: 167-74; PMID: 17784646.
68. Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T, Li Q. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 2011; 7: 36-44; PMID: 21045790; http://dx. doi. org/10. 1038/nrneph. 2010. 152.
69. Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-33; PMID: 16380497; http://dx. doi. org/10. 2337/diabetes. 55. 01. 06. db05-0894.
70. Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Kidney Int 2005; 68: 1583-9; PMID: 16164635; http://dx. doi. org/10. 1111/j. 1523-1755. 2005. 00570. x.
71. Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, Blattner SM, Ikenoue T, Rüegg MA, Hall MN, et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121: 2181-96; PMID: 21606597; http://dx. doi. org/10. 1172/JCI44771.
72. Fang L, Li X, Luo Y, He W, Dai C, Yang J. Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress. Exp Cell Res 2014; 322: 290-301; PMID: 24424244; http://dx. doi. org/10. 1016/j. yexcr. 2014. 01. 001.
73. Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011; 2011: 908185; PMID: 21949662; http://dx. doi. org/10. 1155/2011/908185.
74. Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, Guan KL, Yoshimura A. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 2009; 384: 471-5; PMID: 19422788; http://dx. doi. org/10. 1016/j. bbrc. 2009. 04. 136.
75. Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 2006; 340: 296-301; PMID: 16364254; http://dx. doi. org/10. 1016/j. bbrc. 2005. 12. 012.
76. Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 2007; 27: 495-502; PMID: 17671379; http://dx. doi. org/10. 1159/000106782.
77. Wen X, Wu J, Wang F, Liu B, Huang C, Wei Y. Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radic Biol Med 2013; 65: 402-10; PMID: 23872397; http://dx. doi. org/10. 1016/j. freeradbiomed. 2013. 07. 013.
78. Xu F, Wang Y, Cui W, Yuan H, Sun J, Wu M, Guo Q, Kong L, Wu H, Miao L, et al. Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-kappaB Pathway. Int J Endocrinol 2014; 2014: 289327; PMID: 24672545.
79. Palsamy P, Subramanian S. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 2011; 1812: 719-31; PMID: 21439372; http://dx. doi. org/10. 1016/j. bbadis. 2011. 03. 008.
80. Chang CC, Chang CY, Wu YT, Huang JP, Yen TH, Hung LM. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. J Biomed Sci 2011; 18: 47; PMID: 21699681; http://dx. doi. org/10. 1186/1423-0127-18-47.
81. Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V. Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensinconverting enzyme inhibitor therapy. J Clin Endocrinol Metab 2006; 91: 31-5; PMID: 16219712; http://dx. doi. org/10. 1210/jc. 2005-1632.
82. Bharath LP, Mueller R, Li Y, Ruan T, Kunz D, Goodrich R, Mills T, Deeter L, Sargsyan A, Anandh Babu PV, et al. Impairment of autophagy in endothelial cells prevents shear-stress-induced increases in nitric oxide bioavailability. Can J Physiol Pharmacol 2014; 92: 605-12; PMID: 24941409; http://dx. doi. org/10. 1139/cjpp-2014-0017.
83. Kamijo H, Higuchi M, Hora K. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Nephron Physiol 2006; 104: p12-22; PMID: 16691035; http://dx. doi. org/10. 1159/000093276.
84. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-9; PMID: 16971655; http://dx. doi. org/10. 1681/ASN. 2006070798.
85. Liu Y, Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Rich SS, Bowden DW, Freedman BI. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 2005; 16: 1085-90; PMID: 15743995; http://dx. doi. org/10. 1681/ASN. 2004100817.
86. Wang CH, Li F, Hiller S, Kim HS, Maeda N, Smithies O, Takahashi N. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci U S A 2011; 108: 2070-5; PMID: 21245338; http://dx. doi. org/10. 1073/pnas. 1018766108.
87. Nitta K, Horiba N, Uchida K, Horita S, Hayashi T, Kawashima A, Yumura W, Nihei H. High glucose modulates albumin permeability across glomerular endothelial cells via a protein kinase C-dependent mechanism. Nihon Jinzo Gakkai Shi 1995; 37: 317-22; PMID: 7666597.
88. Singh H, Brindle NP, Zammit VA. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1. Microvasc Res 2010; 79: 121-7; PMID: 20079751; http://dx. doi. org/10. 1016/j. mvr. 2010. 01. 005.
89. Singh SK, Jeansson M, Quaggin SE. New insights into the pathogenesis of cellular crescents. Curr Opin Nephrol Hypertens 2011; 20: 258-62; PMID: 21455064; http://dx. doi. org/10. 1097/MNH. 0b013e32834583ec.
90. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15: 1101-11; PMID: 14699058; http://dx. doi. org/10. 1091/mbc. E03-09-0704.
91. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-1; PMID: 9916792; http://dx. doi. org/10. 1038/5007.
92. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001; 1: 4; PMID: 11299042; http://dx. doi. org/10. 1186/1471-213X-1-4.
93. Bhuiyan MS, Pattison JS, Osinska H, James J, Gulick J, McLendon PM, Hill JA, Sadoshima J, Robbins J. Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 2013; 123: 5284-97; PMID: 24177425; http://dx. doi. org/10. 1172/JCI70877.
94. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K. Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 2004; 66: 91-101; PMID: 15200416; http://dx. doi. org/10. 1111/j. 1523-1755. 2004. 00711. x.
95. Bollee G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; 17: 1242-50; PMID: 21946538; http://dx. doi. org/10. 1038/nm. 2491.
96. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21: 556-63; PMID: 20167701; http://dx. doi. org/10. 1681/ASN. 2010010010.